CLESITAMIG
UNII H57D6SR4FE

Substance Identification & Data

This profile provides standardized clinical and technical data for Clesitamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H57D6SR4FE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2930861-48-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
H57D6SR4FE
CAS Registry Number
2930861-48-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CLESITAMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C198701
National Cancer Institute reference terminology for clinical and research data.
INN ID
13237
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Clesitamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CLESITAMIG

Common Names & Synonyms

CLESITAMIG [INN]
IMMUNOGLOBULIN ((V-KAPPA-G4CH1-G1H-H-GAMMA1_L-KAPPA)_LKAPPA))_(H-GAMMA1_L-KAPPA), ANTI-(HOMO SAPIENS DLL3 (DELTA-LIKE LIGAND 3, DELTA LIKE CANONICAL NOTCH LIGAND 3)), ANTI-(HOMO SAPIENS CD3/TNFRSF9 (TNF RECEPTOR SUPERFAMILY MEMBER 9, 4-1BB, T CELL ANTIGEN ILA, CD137) DUAL NON SIMULTANEOUS), HUMANIZED MONOCLONAL ANTIBODY, TRISPECIFIC, TRIVALENT

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus